ustekinumabupadacitinibUpaIL-22Ulcerative Colitis
… and extracellular matrix (ECM) dysfunction, is associated with ustekinumab and anti-TNF resistance (Pavlidis et al. 2022). Its receptor is…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 273 of 876infliximabvedolizumabsemaglutidetirzepatideGLP-1 RAsinflammatory bowel diseaseIBDobesityCrohn
…ctors associated with obesity in patients with IBD treated with infliximab and vedolizumab across the United Kingdom (UK). Gut 2025;74:A12…
Mixtral 7BMed 42 8BDeepSeek R1 32BDeepSeek R1 14BQwen 32BIBDinflammatory bowel disease
…. Open-weight LLMs (DeepSeek R1 14B, DeepSeek R1 32B, Qwen 32B, Mixtral 7B, Med 42 8B) were deployed via a modular API, with prompts confi…
vedolizumabVDZVDZ95Inflammatory bowel diseaseIBDulcerative colitisTakeda Pharmaceuticals International AGCrohn’s diseasepersonalized treatment
… anti-TNF when starting their first advanced treatment (such as vedolizumab [VDZ]) and describe their demographics/clinical characteristics…
aspirinLMWHlow molecular weight heparingestational diabetesIBDObesity
…patients at risk of pre-eclampsia and VTE were not treated with aspirin or LMWH.Abstract P242 Table 1Normal weight/ overweight (BMI 18.…
96.3%
VedolizumabVDZCrohn’s diseaseCDCDST
…Introduction The Vedolizumab Clinical Decision Support Tool (VDZ-CDST) is a validated tool t…
duloxetineamitriptylineSelective Serotonin Reuptake InhibitorsSerotonin-norepinephrine reuptake inhibitorstricyclic antidepressantsfunctional biliary dyskinesiaSphincter of Oddi dysfunctionfunctional biliary painGoogle ScholarMEDLINE+2 more
…riptyline being most frequently prescribed (n=144), followed by duloxetine (n=39). There was marked variability in agent selection, dosing…
SeladelparSELNumeric Rating Scaleprimary biliary cholangitisNCT04620733PBCPBC-40NCT03301506
…ry cholangitis (PBC) and significantly impairs quality of life. Seladelpar (SEL), a first-in-class delpar (selective PPAR-delta agonist), …
PropranololCarvedilolNSBBscirrhosisUK tertiary centrevariceal bleedingcompensated disease
…world effectiveness across different NSBB agents (Carvedilol vs Propranolol) and the impact on healthcare resource utilisation, including e…
cefoperazone/sulbactamrenal insufficiencymalnutritionsevere infections
…herapy following aortic dissection surgery. After discontinuing cefoperazone/sulbactam and administering vitamin K1, the patient’s coagulation functio…
bevacizumabatezolizumabns‐NSCLCchemoimmunotherapy
…GF-A/VEGFR-1 loop within macrophages.Conclusion The addition of bevacizumab to chemoimmunotherapy was associated with improved survival in …
semaglutideOzempicWegovyIschaemic optic neuropathyIONFDA Adverse Event Reporting SystemWegovy
…cation recently linked to GLP-1 receptor agonists, particularly semaglutide. Using over 30 million reports from the FDA Adverse Event Repor…